New chemotherapy among two drugs accepted for routine use in Scotland’s NHS

11 March 2019 – Express & Star

The Scottish Medicines Consortium has accepted the blood cancer treatment for adults and also a drug to prevent infection following stem cell transplants.

The two drugs were accepted by the Scottish Medicines Consortium (SMC), which provides advice to NHS Scotland about the value of newly licensed medicines.

Liposomal daunorubicin/cytarabine, also known as Vyxeos, was accepted for treating a rare and aggressive blood cancer in adults, known as high risk types of acute myeloid leukaemia (AML).


%d bloggers like this: